Epsom and St Helier University Hospitals NHS Trust Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01273584
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Epsom and St Helier University Hospitals NHS Trust | Epsom & St Helier University Trust

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Cholestasis (Phase 3)

Cholestasis, Intrahepatic (Phase 3)

Kidney Diseases (Phase 3)

Pregnancy Complications (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3